Anti-PIK3IP1 antibody
| Name | Anti-PIK3IP1 antibody |
|---|---|
| Supplier | Abcam |
| Catalog | ab87094 |
| Prices | $370.00 |
| Sizes | 50 µg |
| Host | Rabbit |
| Clonality | Polyclonal |
| Isotype | IgG |
| Applications | WB |
| Species Reactivities | Human |
| Antigen | Synthetic peptide from within residues: ALPAFTTEIQ EASEGPGADE VQVFAPANAL PARSEAAAVQ PVIGISQRVR , corresponding to internal sequence amino acids 108-157 of Human PIK3IP1 (NP_443112) |
| Blocking Peptide | PIK3IP1 peptide |
| Description | Rabbit Polyclonal |
| Gene | PIK3IP1 |
| Conjugate | Unconjugated |
| Supplier Page | Shop |
Product images
Anti-PIK3IP1 antibody (ab87094) at 1 µg/ml + HCT15 cell lysate at 10 µgSecondaryHRP conjugated anti-Rabbit IgG at 1/50000 dilution
All lanes : Anti-PIK3IP1 antibody (ab87094) at 1/1000 dilution (in TBST + 5% Milk for 16 hours at 4°C)Lane 1 : Whole cell lysate of Human U87MG treated with DMSOLane 2 : Whole cell lysate of Human U87MG treated with 1µM LY294002 for 6 hoursLane 3 : Whole cell lysate of Human U87MG treated with 10µM LY294002 for 6 hoursLysates/proteins at 50 µg per lane.SecondaryAn HRP-conjugated Goat anti-rabbit polyclonal at 1/10000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.
Product References
AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic - AT13148 is a novel, oral multi-AGC kinase inhibitor with potent pharmacodynamic
Yap TA, Walton MI, Grimshaw KM, Te Poele RH, Eve PD, Valenti MR, de Haven Brandon AK, Martins V, Zetterlund A, Heaton SP, Heinzmann K, Jones PS, Feltell RE, Reule M, Woodhead SJ, Davies TG, Lyons JF, Raynaud FI, Eccles SA, Workman P, Thompson NT, Garrett MD. Clin Cancer Res. 2012 Jul 15;18(14):3912-23.
Regulation of DMD pathology by an ankyrin-encoded miRNA. - Regulation of DMD pathology by an ankyrin-encoded miRNA.
Alexander MS, Casar JC, Motohashi N, Myers JA, Eisenberg I, Gonzalez RT, Estrella EA, Kang PB, Kawahara G, Kunkel LM. Skelet Muscle. 2011 Aug 8;1:27.